Charles A. Nicolette

Chief Executive Officer at CoImmune, Inc.

61 year

Health Technology

Consumer Services

Profile

Charles A.
Nicolette is currently the Chief Executive Officer & Director at CoImmune, Inc. Previously, he held the position of Director-Antigen Discovery at Genzyme Molecular Oncology and Director at Antigen Discovery.
From 2007 to 2018, he served as the Chief Scientific Officer at Argos Therapeutics, Inc. Dr. Nicolette obtained his undergraduate and doctorate degrees from The State University of New York.

Charles A. Nicolette active positions

Companies	Position	Start
CoImmune, Inc. CoImmune, Inc. Pharmaceuticals: MajorHealth Technology CoImmune, Inc. engages in manufacture and development of cell-based therapeutics. It offers warehouse management, processing suites, logistics, research labs, and qualification and validation. The company was founded in February 2019 and is headquartered in Durham, NC.	Chief Executive Officer	-

All active positions of Charles A. Nicolette

Former positions of Charles A. Nicolette

Companies	Position	End
ARGOS THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	2018-11-29
Genzyme Molecular Oncology Genzyme Molecular Oncology Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Molecular Oncology is a company that develops novel cancer therapeutics and diagnostics. The company is based in Cambridge, MA. The company was founded by Gail J. Maderis.	Corporate Officer/Principal	2002-12-31
Antigen Discovery	Director/Board Member	2002-12-31

See the detail of Charles A. Nicolette's experience

Training of Charles A. Nicolette

The State University of New York

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Charles A. Nicolette's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Argos Therapeutics, Inc. Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC.	Health Technology
Genzyme Molecular Oncology Genzyme Molecular Oncology Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Molecular Oncology is a company that develops novel cancer therapeutics and diagnostics. The company is based in Cambridge, MA. The company was founded by Gail J. Maderis.	Health Technology
Antigen Discovery
CoImmune, Inc. CoImmune, Inc. Pharmaceuticals: MajorHealth Technology CoImmune, Inc. engages in manufacture and development of cell-based therapeutics. It offers warehouse management, processing suites, logistics, research labs, and qualification and validation. The company was founded in February 2019 and is headquartered in Durham, NC.	Health Technology

See company connections